BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32787463)

  • 1. An overview of neuroblastoma cell lineage phenotypes and
    Campos Cogo S; Gradowski Farias da Costa do Nascimento T; de Almeida Brehm Pinhatti F; de França Junior N; Santos Rodrigues B; Cavalli LR; Elifio-Esposito S
    Exp Biol Med (Maywood); 2020 Dec; 245(18):1637-1647. PubMed ID: 32787463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for the Use of SH-SY5Y Neuroblastoma Cells in Neurobiology.
    Kovalevich J; Santerre M; Langford D
    Methods Mol Biol; 2021; 2311():9-23. PubMed ID: 34033074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-149 is associated with clinical outcome in human neuroblastoma and modulates cancer cell proliferation through Rap1 independent of MYCN amplification.
    Xu Y; Chen X; Lin L; Chen H; Yu S; Li D
    Biochimie; 2017 Aug; 139():1-8. PubMed ID: 28456710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.
    Coulon A; Flahaut M; Mühlethaler-Mottet A; Meier R; Liberman J; Balmas-Bourloud K; Nardou K; Yan P; Tercier S; Joseph JM; Sommer L; Gross N
    Neoplasia; 2011 Oct; 13(10):991-1004. PubMed ID: 22028624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient treatment with epigenetic modifiers yields stable neuroblastoma stem cells resembling aggressive large-cell neuroblastomas.
    Ikegaki N; Shimada H; Fox AM; Regan PL; Jacobs JR; Hicks SL; Rappaport EF; Tang XX
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):6097-102. PubMed ID: 23479628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of neuroblastoma cell lines with uncommon TAZ
    Canzonetta C; Pelosi A; Di Matteo S; Veneziani I; Tumino N; Vacca P; Munari E; Pezzullo M; Theuer C; De Vito R; Pistoia V; Tomao L; Locatelli F; Moretta L; Caruana I; Azzarone B
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33452207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived organoids (PDOs) as a novel in vitro model for neuroblastoma tumours.
    Fusco P; Parisatto B; Rampazzo E; Persano L; Frasson C; Di Meglio A; Leslz A; Santoro L; Cafferata B; Zin A; Cimetta E; Basso G; Esposito MR; Tonini GP
    BMC Cancer; 2019 Oct; 19(1):970. PubMed ID: 31638925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sendai virus-mediated expression of reprogramming factors promotes plasticity of human neuroblastoma cells.
    Islam SM; Suenaga Y; Takatori A; Ueda Y; Kaneko Y; Kawana H; Itami M; Ohira M; Yokoi S; Nakagawara A
    Cancer Sci; 2015 Oct; 106(10):1351-61. PubMed ID: 26190440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXD3 is a novel tumor suppressor that affects growth, invasion, metastasis and angiogenesis of neuroblastoma.
    Li D; Mei H; Qi M; Yang D; Zhao X; Xiang X; Pu J; Huang K; Zheng L; Tong Q
    Oncotarget; 2013 Nov; 4(11):2021-44. PubMed ID: 24269992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of novel local and metastatic human neuroblastoma variants.
    Nevo I; Sagi-Assif O; Edry Botzer L; Amar D; Maman S; Kariv N; Leider-Trejo LE; Savelyeva L; Schwab M; Yron I; Witz IP
    Neoplasia; 2008 Aug; 10(8):816-27. PubMed ID: 18683320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Krüppel-like factor 9 promotes neuroblastoma differentiation via targeting the sonic hedgehog signaling pathway.
    Chen S; Gu S; Xu M; Mei D; Xiao Y; Chen K; Yan Z
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28108. PubMed ID: 31782614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Murine neuroblastoma cell lines developed by conditional reprogramming preserve heterogeneous phenotypes observed in vivo.
    Krawczyk E; Hong SH; Galli S; Trinh E; Wietlisbach L; Misiukiewicz SF; Tilan JU; Chen YS; Schlegel R; Kitlinska J
    Lab Invest; 2020 Jan; 100(1):38-51. PubMed ID: 31409888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Krüppel-like factor 4 (KLF4) suppresses neuroblastoma cell growth and determines non-tumorigenic lineage differentiation.
    Shum CK; Lau ST; Tsoi LL; Chan LK; Yam JW; Ohira M; Nakagawara A; Tam PK; Ngan ES
    Oncogene; 2013 Aug; 32(35):4086-99. PubMed ID: 23045286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The deubiquitinating enzyme UCHL1 is a favorable prognostic marker in neuroblastoma as it promotes neuronal differentiation.
    Gu Y; Lv F; Xue M; Chen K; Cheng C; Ding X; Jin M; Xu G; Zhang Y; Wu Z; Zheng L; Wu Y
    J Exp Clin Cancer Res; 2018 Oct; 37(1):258. PubMed ID: 30359286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FUBP1 promotes neuroblastoma proliferation via enhancing glycolysis-a new possible marker of malignancy for neuroblastoma.
    Jiang P; Huang M; Qi W; Wang F; Yang T; Gao T; Luo C; Deng J; Yang Z; Zhou T; Zou Y; Gao G; Yang X
    J Exp Clin Cancer Res; 2019 Sep; 38(1):400. PubMed ID: 31511046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma.
    Chang HH; Chen CH; Chou CH; Liao YF; Huang MJ; Chen YH; Wang WJ; Huang J; Hung JS; Ho WL; Jeng YM; Che MI; Lee H; Lu MY; Yang YL; Jou ST; Lin DT; Lin KH; Hsu WM; Huang MC
    Clin Cancer Res; 2013 Apr; 19(7):1705-16. PubMed ID: 23444218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the smg p25A (a ras p21-like GTP-binding protein) gene in human neuroblastoma cell lines and tumor tissues.
    Sano K; Nakamura H; Mabuchi S; Tanaka T; Nakagawara A; Takai Y
    Cancer Res; 1990 Nov; 50(22):7242-5. PubMed ID: 2121331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a neuroblastoma mouse model by subcutaneous xenograft transplantation and its use to study metastatic neuroblastoma.
    Gao Q; Chen CF; Dong Q; Hou L; Chen X; Zhi YL; Li X; Lu HT; Zhang HY
    Genet Mol Res; 2015 Dec; 14(4):16297-307. PubMed ID: 26662423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma.
    Weng Z; Lin J; He J; Gao L; Lin S; Tsang LL; Zhang H; He X; Wang G; Yang X; Zhou H; Zhao H; Li G; Zou L; Jiang X
    Neuro Oncol; 2022 Jun; 24(6):872-885. PubMed ID: 34655293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating genomic, transcriptomic and clinical data: a prognostic and stem cell-like MYC and PRC imbalance in high-risk neuroblastoma.
    Yang XH; Tang F; Shin J; Cunningham JM
    BMC Syst Biol; 2017 Oct; 11(Suppl 5):92. PubMed ID: 28984200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.